BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 35815370)

  • 1. Does mediastinal lymph node involvement influence the surgical outcome in malign pleural mesothelioma?
    Bedirhan MA; Seyrek Y; Yaran V; Sezen CB; Cansever L; Metin M
    Acta Chir Belg; 2023 Oct; 123(5):517-524. PubMed ID: 35815370
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Extrapleural pneumonectomy in the treatment of epithelioid malignant pleural mesothelioma: novel prognostic implications of combined N1 and N2 nodal involvement based on experience in 529 patients.
    Sugarbaker DJ; Richards WG; Bueno R
    Ann Surg; 2014 Oct; 260(4):577-80; discussion 580-2. PubMed ID: 25203873
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The new case for cervical mediastinoscopy in selection for radical surgery for malignant pleural mesothelioma.
    Nakas A; Waller D; Lau K; Richards C; Muller S
    Eur J Cardiothorac Surg; 2012 Jul; 42(1):72-6; discussion 76. PubMed ID: 22290929
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of lymph node metastasis on outcome after extrapleural pneumonectomy for malignant pleural mesothelioma.
    de Perrot M; Uy K; Anraku M; Tsao MS; Darling G; Waddell TK; Pierre AF; Bezjak A; Keshavjee S; Johnston MR
    J Thorac Cardiovasc Surg; 2007 Jan; 133(1):111-6. PubMed ID: 17198794
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combined modality treatment for malignant pleural mesothelioma: a single-centre long-term survival analysis using extrapleural pneumonectomy.
    Frick AE; Nackaerts K; Moons J; Lievens Y; Verbeken E; Lambrecht M; Coolen J; Dooms C; Vansteenkiste J; De Leyn P; Nafteux P
    Eur J Cardiothorac Surg; 2019 May; 55(5):934-941. PubMed ID: 30535191
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The pattern of lymph node involvement influences outcome after extrapleural pneumonectomy for malignant mesothelioma.
    Edwards JG; Stewart DJ; Martin-Ucar A; Muller S; Richards C; Waller DA
    J Thorac Cardiovasc Surg; 2006 May; 131(5):981-7. PubMed ID: 16678579
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The impact of lymph node station on survival in 348 patients with surgically resected malignant pleural mesothelioma: implications for revision of the American Joint Committee on Cancer staging system.
    Flores RM; Routledge T; Seshan VE; Dycoco J; Zakowski M; Hirth Y; Rusch VW
    J Thorac Cardiovasc Surg; 2008 Sep; 136(3):605-10. PubMed ID: 18805259
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Is Pleurectomy/Decortication Superior to Extrapleural Pneumonectomy for Patients with Malignant Pleural Mesothelioma? A Single-Institutional Experience.
    Miyazaki T; Yamasaki N; Tsuchiya T; Matsumoto K; Kamohara R; Hatachi G; Nagayasu T
    Ann Thorac Cardiovasc Surg; 2018 Apr; 24(2):81-88. PubMed ID: 29367501
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predictors of long-term survival following radical surgery for malignant pleural mesothelioma.
    Nakas A; Waller D
    Eur J Cardiothorac Surg; 2014 Sep; 46(3):380-5; discussion 385. PubMed ID: 24482386
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Radical pleurectomy and chemoradiation for malignant pleural mesothelioma: the outcome of incomplete resections.
    Bölükbas S; Eberlein M; Fisseler-Eckhoff A; Schirren J
    Lung Cancer; 2013 Aug; 81(2):241-6. PubMed ID: 23688589
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term survival after lung-sparing total pleurectomy for locally advanced (International Mesothelioma Interest Group Stage T3-T4) non-sarcomatoid malignant pleural mesothelioma.
    Nakas A; von Meyenfeldt E; Lau K; Muller S; Waller D
    Eur J Cardiothorac Surg; 2012 May; 41(5):1031-6. PubMed ID: 22219469
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Extrapleural pneumonectomies for pleural mesothelioma.
    Faccioli E; Bellini A; Mammana M; Monaci N; Schiavon M; Rea F
    Expert Rev Respir Med; 2020 Jan; 14(1):67-79. PubMed ID: 31674841
    [No Abstract]   [Full Text] [Related]  

  • 13. Comorbidity, postoperative morbidity and survival in patients undergoing radical surgery for malignant pleural mesothelioma.
    Infante M; Morenghi E; Bottoni E; Zucali P; Rahal D; Morlacchi A; Ascolese AM; De Rose F; Navarria P; Crepaldi A; Testori A; Voulaz E; Errico V; Perrino M; Scorsetti M; Chiti A; Santoro A; Alloisio M
    Eur J Cardiothorac Surg; 2016 Dec; 50(6):1077-1082. PubMed ID: 27330149
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A systematic review and meta-analysis of surgical treatments for malignant pleural mesothelioma.
    Cao C; Tian D; Park J; Allan J; Pataky KA; Yan TD
    Lung Cancer; 2014 Feb; 83(2):240-5. PubMed ID: 24360321
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Surgical strategy for malignant pleural mesothelioma: the superiority of pleurectomy/decortication.
    Kanayama M; Mori M; Matsumiya H; Taira A; Shinohara S; Takenaka M; Kuroda K; Tanaka F
    Surg Today; 2022 Jul; 52(7):1031-1038. PubMed ID: 35044520
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Systematic review of quality of life following pleurectomy decortication and extrapleural pneumonectomy for malignant pleural mesothelioma.
    Schwartz RM; Lieberman-Cribbin W; Wolf A; Flores RM; Taioli E
    BMC Cancer; 2018 Nov; 18(1):1188. PubMed ID: 30497433
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Induction chemotherapy, extrapleural pneumonectomy, and adjuvant radiotherapy for malignant pleural mesothelioma: experience of Guy's and St Thomas' hospitals.
    Bille A; Belcher E; Raubenheimer H; Landau D; Cane P; Spicer J; Lang-Lazdunski L
    Gen Thorac Cardiovasc Surg; 2012 May; 60(5):289-96. PubMed ID: 22453539
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Case-control study between extrapleural pneumonectomy and radical pleurectomy/decortication for pathological N2 malignant pleural mesothelioma.
    Martin-Ucar AE; Nakas A; Edwards JG; Waller DA
    Eur J Cardiothorac Surg; 2007 May; 31(5):765-70; discussion 770-1. PubMed ID: 17337201
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lymph node involvement and metastatic lymph node ratio influence the survival of malignant pleural mesothelioma: a French multicenter retrospective study.
    Hysi I; Le Pimpec-Barthes F; Alifano M; Venissac N; Mouroux J; Regnard JF; Riquet M; Porte H
    Oncol Rep; 2014 Jan; 31(1):415-21. PubMed ID: 24142233
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Outcome for patients with malignant pleural mesothelioma referred for Trimodality therapy in Western Australia.
    Hasani A; Alvarez JM; Wyatt JM; Bydder S; Millward M; Byrne M; Musk AW; Nowak AK
    J Thorac Oncol; 2009 Aug; 4(8):1010-6. PubMed ID: 19546819
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.